AIM: To explore primary care physicians' views of the utility and delivery of direct access to pharmacogenomics (PGx) testing in a community health system. METHODS: This descriptive study assessed the perspectives of 15 healthcare providers utilizing qualitative individual interviews. RESULTS: Three main themes emerged: perceived value and utility of PGx testing; challenges to implementation in practice; and provider as well as patient needs. CONCLUSION: While providers in this study viewed benefits of PGx testing as avoiding side effects, titrating doses more quickly, improving shared decision-making and providing psychological reassurance, challenges will need to be addressed such as privacy concerns, cost, insurance coverage and understanding the complexity of PGx test results.
AIM: To explore primary care physicians' views of the utility and delivery of direct access to pharmacogenomics (PGx) testing in a community health system. METHODS: This descriptive study assessed the perspectives of 15 healthcare providers utilizing qualitative individual interviews. RESULTS: Three main themes emerged: perceived value and utility of PGx testing; challenges to implementation in practice; and provider as well as patient needs. CONCLUSION: While providers in this study viewed benefits of PGx testing as avoiding side effects, titrating doses more quickly, improving shared decision-making and providing psychological reassurance, challenges will need to be addressed such as privacy concerns, cost, insurance coverage and understanding the complexity of PGx test results.
Entities:
Keywords:
clinical implementation; clinical utility; personalized medicine; pharmacogenetics; pharmacogenomic testing; pharmacogenomics; primary care physicians; qualitative research
Authors: Sadaf Qureshi; Asam Latif; Laura Condon; Ralph K Akyea; Joe Kai; Nadeem Qureshi Journal: Pharmacogenomics Date: 2021-12-16 Impact factor: 2.638
Authors: Kristin Wiisanen Weitzel; Benjamin Q Duong; Meghan J Arwood; Aniwaa Owusu-Obeng; Noura S Abul-Husn; Barbara A Bernhardt; Brian Decker; Joshua C Denny; Eric Dietrich; John Gums; Ebony B Madden; Toni I Pollin; Rebekah Ryanne Wu; Susanne B Haga; Carol R Horowitz Journal: Pharmacogenomics Date: 2019-10 Impact factor: 2.533
Authors: Emily J Cicali; Kristin Wiisanen Weitzel; Amanda R Elsey; Frank A Orlando; Michelle Vinson; Scott Mosley; D Max Smith; Richard Davis; Lori Drum; David Estores; James P Franciosi; Melanie Gross Hagen; Gabriel J Jerkins; Elvira S Mercado; Jaison Nainaparampil; Adaixa Padron; Eric I Rosenberg; Ashleigh Wright; Siegfried O Schmidt; Carol A Mathews; Larisa H Cavallari; Julie A Johnson Journal: Genet Med Date: 2019-03-30 Impact factor: 8.822
Authors: Ina Liko; Yee Ming Lee; Danielle L Stutzman; Allison B Blackmer; Kimberly M Deininger; Ann M Reynolds; Christina L Aquilante Journal: Pharmacogenomics Date: 2021-03-04 Impact factor: 2.533
Authors: Nicholas J Keeling; Tyler J Dunn; John P Bentley; Sujith Ramachandran; James M Hoffman; Meagen Rosenthal Journal: Genet Med Date: 2021-04-29 Impact factor: 8.822